Naveris
Waltham
About Naveris
Naveris is a biotechnology company that provides highly sensitive blood tests for cancers to enable early diagnosis in the general asymptomatic population, real-time monitoring of response in patients undergoing treatment, and detection of cancer recurrence in patients in remission. The company's 3D biomimetic technology replicates the morphological, signaling, and cell lineage complexity of human tissues and tumors ex vivo. By empowering investigators to efficiently establish patient tumors ex vivo, its technology enables innovative designs for oncology clinical trials and precision medicine that seek to match the right therapies with the right patients. Naveris was founded in 2017 and is headquartered in Waltham, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $66.3M
- Last round: Series Unknown (Jul 2024)
- Website: naveris.com
- Phone: (833)-628-3747
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/naveris-66079 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.